CME Group Inc (NASDAQ:CME) Shares Bought by Royal Bank of Scotland Group PLC

Royal Bank of Scotland Group PLC boosted its stake in CME Group Inc (NASDAQ:CME) by 2.0% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 38,307 shares of the financial services provider’s stock after purchasing an additional 743 shares during the quarter. CME Group comprises about 1.3% of Royal Bank of Scotland Group PLC’s holdings, making the stock its 20th biggest position. Royal Bank of Scotland Group PLC’s holdings in CME Group were worth $5,595,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors also recently bought and sold shares of the company. Quadrant Capital Group LLC lifted its position in shares of CME Group by 13.6% during the second quarter. Quadrant Capital Group LLC now owns 944 shares of the financial services provider’s stock valued at $111,000 after purchasing an additional 113 shares in the last quarter. Valeo Financial Advisors LLC bought a new position in shares of CME Group during the third quarter valued at about $124,000. People s United Financial Inc. lifted its position in shares of CME Group by 11.5% during the second quarter. People s United Financial Inc. now owns 1,063 shares of the financial services provider’s stock valued at $133,000 after purchasing an additional 110 shares in the last quarter. Bank of Nova Scotia Trust Co. bought a new position in shares of CME Group during the third quarter valued at about $165,000. Finally, SeaCrest Wealth Management LLC bought a new position in shares of CME Group during the fourth quarter valued at about $203,000. Institutional investors and hedge funds own 82.85% of the company’s stock.

Shares of CME Group Inc (NASDAQ CME) traded up $0.03 on Wednesday, hitting $160.16. 1,238,300 shares of the stock were exchanged, compared to its average volume of 1,660,223. The company has a market cap of $54,302.48, a price-to-earnings ratio of 13.41, a price-to-earnings-growth ratio of 2.10 and a beta of 0.64. The company has a current ratio of 1.03, a quick ratio of 1.05 and a debt-to-equity ratio of 0.10. CME Group Inc has a 1 year low of $114.82 and a 1 year high of $163.00.

CME Group (NASDAQ:CME) last announced its quarterly earnings data on Thursday, February 1st. The financial services provider reported $1.12 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.10 by $0.02. The firm had revenue of $900.00 million during the quarter, compared to analyst estimates of $886.85 million. CME Group had a net margin of 111.49% and a return on equity of 7.68%. The business’s quarterly revenue was down 1.4% on a year-over-year basis. During the same period in the previous year, the business posted $1.14 EPS. equities research analysts forecast that CME Group Inc will post 6.26 EPS for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, March 26th. Stockholders of record on Friday, March 9th will be issued a $0.70 dividend. This represents a $2.80 dividend on an annualized basis and a dividend yield of 1.75%. This is a positive change from CME Group’s previous quarterly dividend of $0.66. The ex-dividend date is Thursday, March 8th. CME Group’s payout ratio is presently 22.11%.

A number of analysts recently issued reports on the stock. Citigroup raised their price objective on shares of CME Group from $138.00 to $155.00 and gave the stock a “buy” rating in a report on Thursday, October 19th. BidaskClub downgraded shares of CME Group from a “buy” rating to a “hold” rating in a report on Tuesday, December 19th. Berenberg Bank assumed coverage on shares of CME Group in a report on Thursday, January 25th. They set a “hold” rating and a $170.00 price objective for the company. Goldman Sachs Group upgraded shares of CME Group from a “neutral” rating to a “buy” rating and set a $180.00 target price for the company in a research note on Wednesday, February 7th. Finally, Barclays lifted their target price on shares of CME Group from $170.00 to $175.00 and gave the stock an “overweight” rating in a research note on Friday, February 2nd. Three research analysts have rated the stock with a hold rating, eleven have assigned a buy rating and one has assigned a strong buy rating to the company. CME Group presently has a consensus rating of “Buy” and an average target price of $157.00.

In other CME Group news, Chairman Terrence A. Duffy sold 20,000 shares of the business’s stock in a transaction on Tuesday, February 6th. The shares were sold at an average price of $151.66, for a total transaction of $3,033,200.00. Following the transaction, the chairman now directly owns 99,239 shares of the company’s stock, valued at approximately $15,050,586.74. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, Director Jeffrey M. Bernacchi sold 1,501 shares of the business’s stock in a transaction on Thursday, November 30th. The shares were sold at an average price of $149.75, for a total transaction of $224,774.75. Following the transaction, the director now directly owns 60,194 shares in the company, valued at $9,014,051.50. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 67,128 shares of company stock valued at $10,086,157. Company insiders own 0.57% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: “CME Group Inc (NASDAQ:CME) Shares Bought by Royal Bank of Scotland Group PLC” was published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this piece on another publication, it was illegally copied and republished in violation of U.S. and international copyright laws. The original version of this piece can be viewed at https://www.dispatchtribunal.com/2018/02/14/royal-bank-of-scotland-group-plc-raises-holdings-in-cme-group-inc-cme.html.

About CME Group

CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply